Xiaowan Huang

3PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Sep 18, 2026
Cobalt-mediated suppression of IFN-γ-JAK-STAT1 signaling reprograms IDO1-driven immunosuppression for metalloimmunotherapy.

|Feb 29, 2024
Enzyme/pH Dual-Responsive Engineered Nanoparticles for Improved Tumor Immuno-Chemotherapy.

Zefeng Liu, Xiaohan Hao, Jieying Qian

|Jan 12, 2024
Nanoreceptors promote mutant p53 protein degradation by mimicking selective autophagy receptors.

Xiaowan Huang, Ziyang Cao, Jieying Qian

Pageof 1

Frequent Collaborators

3 joint publications

Yunjiao Zhang

1 joint publications

Ziyang Cao

1 joint publications

Guangyu Yao

1 joint publications

Xingwu Wang

1 joint publications

Xianzhu Yang

1 joint publications

Longping Wen

1 joint publications

Tianyi Jiang

1 joint publications

Zhixin Wu

1 joint publications

Hongtao Duan

1 joint publications

Yaoxu Chen

Frequent Collaborators

3 joint publications

Yunjiao Zhang

1 joint publications

Ziyang Cao

1 joint publications

Guangyu Yao

1 joint publications

Xingwu Wang

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us